Regulation of tumor suppressors by nuclear-cytoplasmic shuttling

Experimental Cell Research

Volumn 282, Issue 2, 2003, Pages 59-69

  Fabbro, Megan ^a   Henderson, Beric R ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cancer; Nuclear export; Nuclear transport; Tumor suppressors

Indexed keywords

APC PROTEIN; BETA CATENIN; BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1; BRCA1 PROTEIN; EXPORTIN 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; KARYOPHERIN ALPHA; KARYOPHERIN BETA; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN B56ALPHA; PROTEIN DERIVATIVE; PROTEIN INI1; PROTEIN NLS; PROTEIN P130; PROTEIN P53; PROTEIN P73; SMAD4 PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

CANCER; CANCER GROWTH; CARCINOGENESIS; CELL NUCLEUS; CELL NUCLEUS MEMBRANE; CELL PROLIFERATION; CELL SURVIVAL; CYTOPLASM; GENE INACTIVATION; GENE MUTATION; GENETIC SCREENING; HUMAN; MOLECULAR DYNAMICS; NUCLEAR IMPORT; NUCLEOCYTOPLASMIC TRANSPORT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN TRANSPORT; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

EID: 0037440429     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4827(02)00019-8     Document Type: Review

References (105)

1. Nigg E.A. Nucleocytoplasmic transport Signals, mechanisms and regulation . Nature. 386:1997;779-787.
2. Gorlich D. Transport into and out of the cell nucleus. EMBO J. 17:1998;2721-2727.
3. Moroianu J. Nuclear import and export Transport factors, mechanisms and regulation . Crit. Rev. Euk. Gene Exp. 9:1999;89-106.
4. Jans D.A., Xiao C.-Y., Lam M.H.C. Nuclear targeting signal recognition A key control point in nuclear transport? BioEssays. 22:2000;532-544.
5. Hood J.K., Silver P.A. Diverse nuclear transport pathways regulate cell proliferation and oncogenesis. Biochim. Biophysi. Acta. 1471:2000;M31-M41.
6. Knudson A.G. Antioncogenes and human cancer. Proc. Natl. Acad. Sci. USA. 90:1993;10914-10921.
7. Vogelstein B., Kinzler K.W. The multistep nature of cancer. Trends Genet. 9:1993;138-141.
8. Woods D.B., Vousden K.H. Regulation of p53 function. Exp. Cell Res. 264:2001;56-66.
9. Moll U.M., Riou G., Levine A.J. Two distinct mechanisms alter p53 in breast cancer Mutation and nuclear exclusion . Proc. Natl. Acad. Sci. USA. 89:1992;7262-7266.
10. Chen Y., Chen C.-F., Riley D.J., Allred D.C., Chen P.-L., Hoff D.V., Osbome C.K., Lee W.-H. Aberrant subcellular localization of BRCA1 in breast cancer. Science. 270:1995;789-791.
11. Taylor J., Lymboura M., Pace P.E., Hem R.P.A., Desai A.J., Shousha S., Coombes R.C., Ali S. An important role for BRCA1 in breast cancer progression is indicated by its loss in a large proportion of non-familial breast cancers. Int. J. Cancer. 79:1998;334-342.
12. Shaulsky G., Goldfinger N., Benzeev A., Rotter V. Nuclear accumulation of p53 protein is mediated by several nuclear-localization signals and plays a role in tumorigenesis. Mol. Cell. Biol. 10:1990;6565-6577.
13. Kalderon D., Roberts B.L., Richardson W.D., Smith A.E. A short amino acid sequence able to specify nuclear location. Cell. 39:1984;499-509.
14. Dingwall C., Laskey R.A. Nuclear targeting sequences - A consensus? Trends Biol. Sci. 16:1991;178-181.
15. Liang S.-H., Clarke M.F. A bipartite nuclear localization signal is required for p53 nuclear import regulated by a carboxyl-terminal domain. J. Biol. Chem. 274:1999;32699-32703.
16. Corbett A.H., Silver P.A. Nucleocytoplasmic transport of macromolecules. Microbiol. Mol. Biol. Rev. 61:1997;193-211.
17. Pemberton L.F., Blobel G., Rosenblum J.S. Transport routes through the nuclear pore complex. Curr. Opin. Cell Biol. 10:1998;392-399.
18. Moore M.S., Blobel G. The GTP-binding protein Ran/TC4 is required for protein import into the nucleus. Nature. 365:1993;661-663.
19. Zhang F., White R.L., Neufeld K.L. Phosphorylation near nuclear localization signals regulates nuclear import of adenomatous polyposis coli protein. Proc. Natl. Acad. Sci. USA. 97:2000;12577-12582.
20. Chen C.-F., Li S., Chen Y., Chen P.-L., Sharp Z.D., Lee W.-H. The nuclear localization sequences of the BRCA1 protein interact with the importin-α subunit of the nuclear transport signal. J. Biol. Chem. 271:1996;32863-32868.
21. Thakur S., Zhang H.B., Peng Y., Le H., Carroll B., Ward T., Yao J., Farid L.M., Couch F.J., Wilson R.B., Weber B.L. Localization of BRCA1 and a splice variant identifies the nuclear localization signal. Mol. Cell. Biol. 17:1997;444-452.
22. Inoue, T., Stuart, J., Leno, R. and Maki, C.G. (2002). Nuclear import and export signals in control of the p53-related protein p73. J. Biol. Chem.277, 15053-15060.
23. Lee S., Chen D.Y.T., Humphrey J.S., Gnarra J.R., Linehan W.M., Klausner R.D. Nuclear/cytoplasmic localization of the von Hippel-Lindau tumor suppressor gene product is determined by cell density. Proc. Natl. Acad. Sci. USA. 93:1996;1770-1775.
24. Chestukhin A., Litovchick L., Rudich K., DeCaprio J.A. Nucleocytoplasmic shuttling of p130/RBL2 Novel regulatory mechanism . EMBO J. 22:2002;453-468.
25. Pierreux C.E., Nicolas F.J., Hill C.S. Transforming growth factor beta-independent shuttling of Smad4 between the cytoplasm and nucleus. Mol. Cell Biol. 20:2000;9041-9054.
26. Galea M.A., Eleftheriou A., Henderson B.R. ARM domain-dependent nuclear import of adenomatous polyposis coli protein is stimulated by the B56α subunit of protein phosphatase 2A. J. Biol. Chem. 276:2001;45833-45839.
27. Peifer M., Berg S., Reynolds A.B. A repeating amino acid motif shared by proteins with diverse cellular roles. Cell. 76:1994;789-791.
28. Fagotto F., Gluck U., Gumbiner B.M. Nuclear localization signal-independent and importin/karyopherin-independent nuclear import of beta-catenin. Curr. Biol. 8:1998;181-190.
29. Fabbro M., Rodriguez J.A., Baer R., Henderson B.R. BARD1 induces BRCA1 intranuclear foci formation by increasing RING-dependent BRCA1 nuclear import and inhibiting BRCA1 nuclear export. J. Biol. Chem. 277:2002;21315-21324.
30. Wu L.C., Wang Z.W., Tsan J.T., Spillman M.A., Phung A., Xu X.L., Yang M.C., Hwang L.Y., Bowcock A.M., Baer R. Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nat. Genet. 14:1996;430-440.
31. Brzovic P.S., Rajagopal P., Hoyt D.W., King M.C., Klevit R.E. Structure of a BRCA1-BARD1 heterodimeric RING-RING complex. Nat. Struct. Biol. 8:2001;833-837.
32. Bogerd A.M., Fridell R.A., Benson R.E., Hua J., Cullen B.R. Protein sequence requirements for function of the human T-cell leukemia cirus type 1 Rex nuclear export signal delineated by a novel in vivo randomization selection assay. Mol. Cell. Biol. 16:1996;4207-4214.
33. Henderson B.R., Eleftheriou A. A comparison of the activity, sequence specificity, and CRM1-dependence of different nuclear export signals. Exp. Cell Res. 256:2000;213-224.
34. Fornerod M., Ohno M., Yoshida M., Mattaj I.W. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell. 90:1997;1051-1060.
35. Ossareh-Nazari B., Bachelerie F., Dargemont C. Evidence for a role of CRM1 in signal-mediated nuclear protein export. Science. 278:1997;141-144.
36. Stade K., Ford C.S., Guthrie C., Weis K. Exportin (Crm1p) is an essential nuclear export factor. Cell. 90:1997;1041-1050.
37. Fukuda M., Asano S., Nakamura T., Adachi M., Yoshida M., Yanagida M., Nishida E. CRM1 is responsible for intracellular transport mediated by the nuclear export signal. Nature. 390:1997;308-311.
38. Fischer U., Huber J., Boelens W.C., Mattaj L.W., Luhrmann R. The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell. 82:1995;475-483.
39. Wolff B., Sanglier J.J., Wang Y. Leptomycin B is an inhibitor of nuclear export Inhibition of nucleo-cytoplasmic translocation of the human imunodeficiency virus type-1 (HIV-1) Rev protein and Rev-dependent mRNA . Chem. Biol. 4:1997;139-147.
40. Kudo N., Wolff B., Sekimoto T., Schreiner E.P., Yoneda Y., Yanagida M., Horinouchi S., Yoshida M. Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. Exp. Cell Res. 242:1998;540-547.
41. Michael W.M., Choi M., Dreyfuss G. A nuclear export signal in hnRNPA1 A signal-mediated, temperature-dependent nuclear protein export pathway . Cell. 83:1995;415-422.
42. Michael W.M., Eder P.S., Dreyfuss G. The K nuclear shuttling domain A novel signal for nuclear import and nuclear export in the hnRNP K protein . EMBO J. 16:1995;3587-3598.
43. Fan X.C., Steitz J.A. HNS, a nuclear-cytoplasmic shuttling sequence in HuR. Proc. Natl. Acad. Sci. USA. 95:1998;15293-15298.
44. Holaska J.M., Black B.E., Love D.C., Hanover J.A., Leszyk J., Paschal B.M. Calreticulin is a receptor for nuclear export. J. Cell Biol. 152:2001;127-140.
45. Lee S., Neumann M., Stearman R., Stauber R., Pause A., Pavlakis G.N., Klausner R.D. Transcription-dependent nuclear-cytoplasmic trafficking is required for the function of the von Hippel-Lindau tumour suppressor protein. Mol. Cell. Biol. 19:1999;1486-1497.
46. Groulx I., Bonicalzi M.-E., Lee S. Ran-mediated nuclear export of the von Hippel Lindau tumor suppressor protein occurs independently of its assembly with cullin-2. J. Biol. Chem. 275:2000;8991-9000.
47. Zhu J., McKeon F. NF-AT activation requires suppression of Crm1-dependent export by calcineurin. Nature. 398:1999;256-260.
48. Berthelsen J., Kilstrup-Nielsen C., Blasi F., Mavilio F., Zappavigna V. The subcellular localization of PBX1 and EXD proteins depends on nuclear import and export signals and is modulated by association with PREP1 and HTH. Genes Dev. 13:1999;946-953.
49. Karki S., Holzbaur E.L.F. Cytoplasmic dynein and dynactin in cell division and intracellular transport. Curr. Opin. Cell Biol. 11:1999;45-53.
50. El-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., Vogelstein B. a potential mediator of p53 tumour suppression. Cell. 75:1993;817-825.
51. Harper J.W., Adami G.R., Wei N., Keyomarsi K., Elledge S.J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 75:1993;805-816.
52. Miyashita T., Reed J.C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell. 80:1995;293-299.
53. Barak Y., Juven T., Haffner R., Oren M. mdm2 expression is induced by wild type p53 activity. EMBO J. 12:1993;461-468.
54. Stommel J.M., Marchenko N.D., Jimenez G.S., Moll U.M., Hope T.J., Wahl G.M. A leucine-rich nuclear export signal in the p53 tetramerization domain Regulation of subcellular localization and p53 activity by NES masking . EMBO J. 18:1999;1160-1172.
55. Scully R., Livingston D.M. In search of the tumor-suppressor functions of BRCA1 and BRCA2. Nature. 408:2000;429-432.
56. Baer R., Ludwig T. The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity. Curr. Opin. Gen. Dev. 12:2002;86-91.
57. Joukov V., Chen J., Fox E.A., Green J.B.A., Livingston D.M. Functional communication between endogenous BRCA1 and its partner, BARD1, during Xenopus laevis development. Proc. Natl. Acad. Sci. USA. 90:2001;12078-12083.
58. Wang W. Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. EMBO J. 15:1996;5370-5382.
59. Craig E., Zhang Z.K., Davies K.P., Kalpana G.V. A masked NES in INI1/hSNF5 mediates hCRM1-dependent nuclear export Implications for tumorigenesis . EMBO J. 21:2002;31-42.
60. Zhang Y., Xiong Y. A p53 amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation. Science. 292:2001;1910-1915.
61. Roth J., Dobbelstein M., Freedman D.A., Shenk T., Levine A.J. Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. EMBO J. 17:1998;554-564.
62. Tao W., Levine A.J. Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53. Proc. Natl. Acad. Sci. USA. 96:1999;3077-3080.
63. Boyd S.D., Tsai K.Y., Jacks T. An intact HDM2 RING-finger domain is required for nuclear exclusion of p53. Nat. Cell Biol. 2:2000;563-568.
64. Geyer R.K., Yu Z.K., Maki C.G. The MDM2 RING-finger domain is required to promote p53 nuclear export. Nat. Cell Biol. 2:2000;569-573.
65. Gu J., Nei L., Weiderschain D., Yuan Z.-M. Identification of p53 sequence elements that are required for MDM2-mediated nuclear export. Mol. Cell Biol. 21:2001;8533-8546.
66. Lohrum M.A.E., Woods D.B., Ludwig R.L., Balint E., Vousden K.H. C-terminal ubiquination of p53 contributes to nuclear export. Mol. Cell Biol. 21:2001;8521-8532.
67. Kwek S.S., Derry J., Tyner A.L., Shen Z., Gudkov A.V. Functional analysis and intracellular localization of p53 modified by SUMO-1. Oncogene. 20:2001;2587-2599.
68. Gu W., Roeder R.G. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell. 90:1997;595-606.
69. Shaw P., Freeman J., Bovey R., Iggo R. Regulation of specific DNA binding by p53 Evidence for a role for O-glycosylation and charged residues at the carboxy-terminus . Oncogene. 12:1996;921-930.
70. Wesierska-Gadek J., Bugajska-Schretter A., Cemi C. ADP-ribosylation of p53 tumor suppressor protein Mutant but not wild-type p53 is modified . J. Cell. Biochem. 62:1996;90-101.
71. Wesierska-Gadek J., Schmid G., Cemi C. ADP-ribosylation of wild-type p53 in vitro Binding of p53 protein to specific p53 consensus sequence prevents its modification . Biochem. Biophys. Res. Commun. 224:1996;96-102.
72. Appella E., Anderson C.W. Post-translational modifications and activation of p53 by genotoxic stresses. Eur. J. Biochem. 268:2001;2764-2772.
73. Neufeld K.L., White R.L. Nuclear and cytoplasmic localizations of the adenomatous polyposis coli protein. Proc. Natl. Acad. Sci. USA. 94:1997;3034-3039.
74. Henderson B.R. Nuclear-cytoplasmic shuttling of APC regulates β-catenin subcellular localization and turnover. Nat. Cell Biol. 2:2000;653-660.
75. Neufeld Z.L., Zhang F., Cullen B.R., White R.L. APC-mediated downregulation of beta-catenin activity involves nuclear sequestration and nuclear export. EMBO Rep. 1:2000;519-523.
76. Rosin-Arbesfeld R., Townsley F., Bienz M. A nuclear export function of the APC tumour suppressor. Nature. 406:2000;1009-1012.
77. Zhang F., White R.L., Neufeld K.L. Cell density and phosphorylation control the subcellular localization of adenomatous polyposis coli protein. Mol. Cell Biol. 21:2001;8143-8156.
78. Munemitsu S., Souza B., Muller O., Albert L., Rubinfeld B., Polakis P. The APC gene product associates with microtubules in vivo and promotes their assembly in vitro. J. Cell Biol. 148:1994;505-517.
79. Smith K.J., Levy D.B., Maupin P., Pollard T.D., Vogelstein B., Kinzler K.W. Wild-type but not mutant APC associates with the microtubule cytoskeleton. Cancer Res. 54:1994;3672-3675.
80. Mimori-Kiyosue Y., Shiina N., Tsukita S. Adenomatous polyposis coli (APC) protein moves along microtubules and concentrates at their growing ends in epithelial cells. J. Cell Biol. 148:2000;505-517.
81. Sengupta S., Vonesch J.L., Waltzinger C., Zheng H., Wasylyk B. Negative cross-talk between p53 and the glucocorticoid receptor and its role in neuroblastoma cells. EMBO J. 19:2000;6051-6064.
82. Li S., Ku C.-Y., Farmer A.A., Cong Y.-S., Chen C.-F., Lee W.-H. Identification of a novel cytoplasmic protein that specifically binds to nuclear localization signal motifs. J. Biol. Chem. 273:1998;6183-6189.
83. Liang S.H., Hong D., Clarke M.F. Cooperation of a single lysine mutation and a C-terminal domain in the cytoplasmic sequestration of the p53 protein. J. Biol. Chem. 273:1998;19817-19821.
84. Liang S.H., Clarke M.F. The nuclear import of p53 is determined by the presence of a basic domain and its relative position to the nuclear localization signal. Oncogene. 18:1999;2163-2166.
85. Perry M.E., Mendrysa S.M., Saucedo L.J., Tannous P., Holubar M. p76 (MDM2) inhibits the ability of p90 (MDM2) to destabilize p53. J. Biol. Chem. 275:2000;5733-5738.
86. Sionov R.V., Coen S., Goldberg Z., Berger M., Bercovich B., Ben-Neriah Y., Ciechanover A., Haupt Y. c-Abl regulates p53 levels under normal and stress conditions by preventing its nuclear export and ubiquitination. Mol. Cell Biol. 21:2001;5869-5878.
87. Weber J.D., Taylor L.J., Roussel M.F., Sherr C.J., Bar-Sagi D. Nucleolar Arf sequesters Mdm2 and activates p53. Nat. Cell Biol. 1:1999;20-26.
88. Midgley C.A., Desterro J.M., Saville M.K., Howard S., Sparks A., Hay R.T., Lane D.P. An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo. Oncogene. 19:2000;2312-2323.
89. Hsieh J.K., Chan F.S., O'Connor D.J., Modjtahedi S., Zhong S., Lu X. RB regulatesc the stability and the apoptotic function of p53 via MDM2. Mol. Cell. 3:1999;181-193.
90. Baba M., Hirai S., Kazwakami S., Kishida T., Sakai N., Kaneko S., Yao M., Shuin T., Kubota Y., Hosaka M., Ohno S. Tumor suppressor protein VHL is induced at high cell density and mediates contact inhibition of cell growth. Oncogene. 20:2001;2727-2736.
91. Zhuang Z., Gnarra J.R., Dudley C.F., Zbar B., Linehan W.M., Lubensky I.A. Detection of von Hippel-Lindau disease gene mutations in paraffin-embedded sporadic renal cell carcinoma specimens. Mod. Pathol. 9:1996;838-842.
92. Fodde R., Smits R., Clevers H. APC, signal transduction and genetic instability in colorectal cancer. Nat. Rev. Cancer. 1:2001;55-67.
93. Tanimoto K., Makino Y., Pereira T., Poellinger L. Mechanism of regulation of the hypoxia-inducible factor-1α by the von Hippel-Lindau tumor suppressor protein. EMBO J. 19:2000;4298-4309.
94. Groutx I., Lee S. Oxygen-dependent ubiquitination and degradation of hypoxia-inducible factor requires nuclear-cytoplasmic trafficking of the von Hippel-Lindau tumor suppressor protein. Mol. Cell. Biol. 22:2002;5319-5336.
95. Lorick K.L., Jensen J.P., Fang S., Ong A.M., Hatakeyama S. RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc. Natl. Acad. Sci. USA. 96:1999;11354-11369.
96. Hashizume R., Fukuda M., Maeda I., Nishikawa H., Oyake D., Yabuki Y., Ogata H., Ohta T. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation. J. Biol. Chem. 276:2001;14537-14540.
97. Ruffner H., Joazeiro C.A.P., Hemmati D., Hunter T., Verma I.M. Cancer-predisposing mutations within the RING domain of BRCA1 Loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity . Proc. Nat. Acad. Sci. USA. 98:2001;5134-5139.
98. Chen A., Kleiman F.E., Manley J.L., Ouchi T., Pan Z.-Q. Auto-ubiquitination of the BRCA1/BARD1 RING ubiquitin ligase. J. Biol. Chem. 277:2002;22085-22092.
99. Liang X.H., Yu J., Brown K., Levine B. Beclin 1 contains a leucine-rich nuclear export signal that is required for its autophagy and tumor suppressor function. Cancer Res. 61:2001;3443-3449.
100. Wilson C.A., Ramos L., Villasenor M.R., Anders K.H., Press M.F., Clarke K., Karlan B., Chen J.-J., Scully R., Livingston D., Zuch R.H., Kanter M.H., Cohen S., Calzone F.J., Slamon D.J. Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas. Nat. Genet. 21:1999;236-240.
101. Daniel M.T., Koken M., Romagne O., Barbey S., Bazarbachi A., Stadler M., Guillemin M.C., Degos L., Chomienne C., The H.D. PML protein expression in hematopoietic and acute promyelocytic leukemia cells. Blood. 82:1993;1858-1867.
102. Rodriguez J.A., Henderson B.R. Identification of a functional nuclear export signal in BRCA1. J. Biol. Chem. 275:2000;38589-38596.
103. Neufeld K.L., Nix D.A., Bogerd H., Kang Y., Beckerle M.C., Cullen B.R., White R.L. Adenomatous polyposis coli protein contains two nuclear export signals and shuttles between the nucleus and cytoplasm. Proc. Natl. Acad. Sci. USA. 97:2000;12085-12090.
104. Watanabe M., Masuyama N., Fukuda M., Nishida E. Regulation of intracellular dynamics of Smad4 by its leucine-rich nuclear export signal. EMBO Rep. 1:2000;176-182.
105. Crook T., Parker G.A., Rozycka M., Crossland S., Allday M.J. A transforming p53 mutant, which binds DNA transactivates and induces apoptosis reveals a nuclear Cytoplasmic shuttling detect . Oncogene. 16:1998;1429-1441.